Pfizer to acquire Medivation for US$14b
01:09 Min
23 Aug 2016 02:42am
Pharmaceutical giant Pfizer has agreed to buy cancer drug-maker Medivation for US$14 billion. The New York-based company announced the agreement after weeks of speculation about the buyer of the very desirable biotech. Nick Harper reports from New York.
Popular Shows
